Zomedica Announces Up to $10 Million Private Offering of Common Shares
15 mai 2018 16h01 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., May 15, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (the "Company"), a veterinary diagnostic and pharmaceutical company, today announced...
Zomedica Signs Agreement With Seraph Biosciences for Innovative Veterinary Point-of-Care Diagnostic
10 mai 2018 06h55 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., May 10, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM), a veterinary diagnostic and pharmaceutical company, today announced it has entered...
Zomedica to Present at 2018 Disruptive Growth & Healthcare Conference
07 mai 2018 06h55 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., May 07, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM), a veterinary diagnostic and pharmaceutical company, today announced that it will...
Zomedica to Present at 30th Annual ROTH Conference
07 mars 2018 06h55 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., March 07, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM), a veterinary diagnostic and pharmaceutical company, today announced that it will...
Zomedica Pharmaceuticals Corp. Announces Year End 2017 Financial Results
28 févr. 2018 16h11 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company,...
Zomedica to Participate in the Bank of America Merrill Lynch Animal Health Summit
20 févr. 2018 06h55 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company,...
Zomedica Pharmaceuticals Corp. Enters into License and Supply Agreement with Celsee, Inc. for Cancer Liquid Biopsy Platform
21 déc. 2017 06h55 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and diagnostic company,...
Zomedica Announces Achievement of Therapeutic Development Milestones
12 déc. 2017 06h55 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and diagnostic company,...
Zomedica Pharmaceuticals Corp. Registration Statement Declared Effective by U.S. Securities and Exchange Commission
20 nov. 2017 18h51 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Nov. 20, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (NYSE American:ZOM) (Zomedica or the Company), a veterinary pharmaceutical and health care solutions...
Zomedica Pharmaceuticals Corp. Expects Trading of its Common Shares on the NYSE American to Commence on November 21, 2017
16 nov. 2017 09h12 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (NYSE American:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions...